N
4.72
0.02 (0.43%)
| Penutupan Terdahulu | 4.70 |
| Buka | 4.65 |
| Jumlah Dagangan | 101,656 |
| Purata Dagangan (3B) | 660,373 |
| Modal Pasaran | 175,976,704 |
| Harga / Jualan (P/S) | 0.350 |
| Harga / Buku (P/B) | 0.550 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Oct 2024 - 4 Nov 2024 |
| Margin Keuntungan | -16.54% |
| Margin Operasi (TTM) | -15.66% |
| EPS Cair (TTM) | -1.87 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -6.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 90.24% |
| Nisbah Semasa (MRQ) | 5.02 |
| Aliran Tunai Operasi (OCF TTM) | -46.96 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -24.21 M |
| Pulangan Atas Aset (ROA TTM) | -9.02% |
| Pulangan Atas Ekuiti (ROE TTM) | -24.78% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Nevro Corp. | Menurun | Menurun |
AISkor Stockmoo
-0.3
| Konsensus Penganalisis | -1.5 |
| Aktiviti Orang Dalam | 0.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.30 |
|
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 3.66% |
| % Dimiliki oleh Institusi | 102.73% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Palo Alto Investors Lp | 30 Jun 2024 | 750,371 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 7.00 (RBC Capital, 48.31%) | Pegang |
| Median | 4.85 (2.75%) | |
| Rendah | 4.00 (Wells Fargo, -15.25%) | Pegang |
| 4.00 (Canaccord Genuity, -15.25%) | Pegang | |
| 4.00 (Morgan Stanley, -15.25%) | Jual | |
| Purata | 5.09 (7.84%) | |
| Jumlah | 6 Pegang, 2 Jual | |
| Harga Purata @ Panggilan | 4.52 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Truist Securities | 18 Dec 2024 | 4.70 (-0.42%) | Pegang | 3.74 |
| Citigroup | 11 Dec 2024 | 5.00 (5.93%) | Pegang | 4.31 |
| Wells Fargo | 11 Dec 2024 | 4.00 (-15.25%) | Pegang | 4.31 |
| 03 Dec 2024 | 5.00 (5.93%) | Pegang | 4.26 | |
| Canaccord Genuity | 09 Dec 2024 | 4.00 (-15.25%) | Pegang | 4.35 |
| 12 Nov 2024 | 7.00 (48.31%) | Pegang | 5.06 | |
| Morgan Stanley | 02 Dec 2024 | 4.00 (-15.25%) | Jual | 4.27 |
| Baird | 12 Nov 2024 | 6.00 (27.12%) | Pegang | 5.06 |
| Piper Sandler | 12 Nov 2024 | 6.00 (27.12%) | Jual | 5.06 |
| RBC Capital | 12 Nov 2024 | 7.00 (48.31%) | Pegang | 5.06 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| RASHID KASHIF | - | 3.71 | -527 | -1,955 |
| Jumlah Keseluruhan Kuantiti Bersih | -527 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,955 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 3.71 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| RASHID KASHIF | Pegawai | 04 Jan 2025 | Dibuang (-) | 527 | 3.71 | 1,955 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 Jan 2025 | Pengumuman | Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results |
| 17 Dec 2024 | Pengumuman | Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 |
| 18 Nov 2024 | Pengumuman | New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches |
| 15 Nov 2024 | Pengumuman | Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 |
| 12 Nov 2024 | Pengumuman | Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally |
| 11 Nov 2024 | Pengumuman | Nevro Reports Third-Quarter 2024 Financial Results |
| 29 Oct 2024 | Pengumuman | New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy |
| 16 Oct 2024 | Pengumuman | Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |